DLK1, a serum marker for hepatoblastoma in young infants
Pediatric Blood & Cancer2011Vol. 59(4), pp. 743–745
Citations Over Time
Abstract
Hepatoblastoma is a malignant pediatric liver tumor. The currently used diagnostic serum marker for hepatoblastoma, α-fetoprotein (AFP), is not always reliable in infants with hepatoblastoma, due to the physiologically elevated levels of AFP in this age group. In this report, we show that Delta-like 1 homolog (DLK1), a protein highly expressed during fetal development, but almost completely absent after birth, and an established liver-stem cell marker, is a new candidate serum marker of hepatoblastoma, especially in young infants.
Related Papers
- → Radiofrequency ablation in the treatment of liver tumors in children(2012)24 cited
- Resection of Huge Liver Tumor in Children(2008)
- → Resection of Huge Liver Tumor in Children(2008)
- → Liver Tumors(2022)
- → Liver Tumors(2011)